Leivonen SK - Search Results

1

Protein lysate microarray analysis to identify microRNAs regulating estrogen receptor signaling in breast cancer cell lines.

Leivonen SK, Mäkelä R, Ostling P, Kohonen P, Haapa-Paananen S, Kleivi K, Enerly E, Aakula A, Hellström K, Sahlberg N, Kristensen VN, Børresen-Dale AL, Saviranta P, Perälä M, Kallioniemi O. Leivonen SK, et al. Oncogene. 2009 Nov 5;28(44):3926-36. doi: 10.1038/onc.2009.241. Epub 2009 Aug 17. Oncogene. 2009. PMID: 19684618

2

Identifying microRNAs regulating B7-H3 in breast cancer: the clinical impact of microRNA-29c.

Nygren MK, Tekle C, Ingebrigtsen VA, Mäkelä R, Krohn M, Aure MR, Nunes-Xavier CE, Perälä M, Tramm T, Alsner J, Overgaard J, Nesland JM, Borgen E, Børresen-Dale AL, Fodstad Ø, Sahlberg KK, Leivonen SK. Nygren MK, et al. Among authors: leivonen sk. Br J Cancer. 2014 Apr 15;110(8):2072-80. doi: 10.1038/bjc.2014.113. Epub 2014 Feb 27. Br J Cancer. 2014. PMID: 24577056 Free PMC article.

3

Excess of miRNA-378a-5p perturbs mitotic fidelity and correlates with breast cancer tumourigenesis in vivo.

Winsel S, Mäki-Jouppila J, Tambe M, Aure MR, Pruikkonen S, Salmela AL, Halonen T, Leivonen SK, Kallio L, Børresen-Dale AL, Kallio MJ. Winsel S, et al. Among authors: leivonen sk. Br J Cancer. 2014 Nov 25;111(11):2142-51. doi: 10.1038/bjc.2014.524. Epub 2014 Sep 30. Br J Cancer. 2014. PMID: 25268374 Free PMC article.

4

Activation of Smad signaling enhances collagenase-3 (MMP-13) expression and invasion of head and neck squamous carcinoma cells.

Leivonen SK, Ala-Aho R, Koli K, Grénman R, Peltonen J, Kähäri VM. Leivonen SK, et al. Oncogene. 2006 Apr 27;25(18):2588-600. doi: 10.1038/sj.onc.1209291. Oncogene. 2006. PMID: 16407850

5

Alternative splicing discriminates molecular subtypes and has prognostic impact in diffuse large B-cell lymphoma.

Leivonen SK, Taskinen M, Cervera A, Karjalainen-Lindsberg ML, Delabie J, Holte H, Lehtonen R, Hautaniemi S, Leppä S. Leivonen SK, et al. Blood Cancer J. 2017 Aug 25;7(8):e596. doi: 10.1038/bcj.2017.71. Blood Cancer J. 2017. PMID: 28841210 Free PMC article. Clinical Trial.

6

Serum protein profiling reveals an inflammation signature as a predictor of early breast cancer survival.

Karihtala P, Leivonen SK, Puistola U, Urpilainen E, Jääskeläinen A, Leppä S, Jukkola A. Karihtala P, et al. Among authors: leivonen sk. Breast Cancer Res. 2024 Apr 9;26(1):61. doi: 10.1186/s13058-024-01812-x. Breast Cancer Res. 2024. PMID: 38594742 Free PMC article.

7

Inflammatory and subtype-dependent serum protein signatures predict survival beyond the ctDNA in aggressive B cell lymphomas.

Arffman M, Meriranta L, Autio M, Holte H, Jørgensen J, Brown P, Jyrkkiö S, Jerkeman M, Drott K, Fluge Ø, Björkholm M, Karjalainen-Lindsberg ML, Beiske K, Pedersen MØ, Leivonen SK, Leppä S. Arffman M, et al. Among authors: leivonen sk. Med. 2024 Apr 2:S2666-6340(24)00119-3. doi: 10.1016/j.medj.2024.03.007. Online ahead of print. Med. 2024. PMID: 38579729 Free article.

8

Intra-patient evolution of tumor microenvironment in the pathogenesis of treatment-naïve metastatic melanoma patients.

Kohtamäki L, Leivonen SK, Mäkelä S, Juteau S, Leppä S, Hernberg M. Kohtamäki L, et al. Among authors: leivonen sk. Acta Oncol. 2023 Sep;62(9):1008-1013. doi: 10.1080/0284186X.2023.2248371. Epub 2023 Aug 25. Acta Oncol. 2023. PMID: 37624703 No abstract available.

9

Characterization and clinical impact of the tumor microenvironment in post-transplant aggressive B-cell lymphomas.

Leivonen SK, Friman T, Autio M, Vaittinen S, Jensen AW, D'Amore F, Hamilton-Dutoit SJ, Holte H, Beiske K, Kovanen PE, Räty R, Leppä S. Leivonen SK, et al. Haematologica. 2023 Nov 1;108(11):3044-3057. doi: 10.3324/haematol.2023.282831. Haematologica. 2023. PMID: 37259566 Free PMC article.

10

High-throughput screen in vitro identifies dasatinib as a candidate for combinatorial treatment with HER2-targeting drugs in breast cancer.

Normann LS, Haugen MH, Hongisto V, Aure MR, Leivonen SK, Kristensen VN, Tahiri A, Engebraaten O, Sahlberg KK, Mælandsmo GM. Normann LS, et al. Among authors: leivonen sk. PLoS One. 2023 Jan 27;18(1):e0280507. doi: 10.1371/journal.pone.0280507. eCollection 2023. PLoS One. 2023. PMID: 36706086 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

49 results

Search Page